ADDEX THERAPEUTICS LTD

Stable Addex Therapeutics (ADXN.SW) trades flat at CHF 0.02, but its allosteric modulator pipeline and upcoming clinical milestones could spark a price rally.

Explore Addex Therapeutics’ rise: low‑cap biotech with allosteric modulators, recent 5.8% rally, strong peer comparison, and key milestones to watch for next catalyst.

Addex Therapeutics (ADXN.SW) drops 4.55% to CHF 0.02 as a low‑cap allosteric modulator biotech; see the latest price, volume, and peer comparison.